Advertisement

The 50/50 cc Total Artificial Heart Trial: Extending the Benefits of the Total Artificial Heart to Underserved Populations

      While use of the total artificial heart (TAH) is growing, the use of the device is not uniform across the gender and age spectrum because the vast majority of implants are in adult males. SynCardia has recently developed a smaller 50 cc TAH that was designed to accommodate patients with a body surface area as low as 1.2 m2 (potentially even lower using virtual implantation). Herein, we describe the early use of the 50 cc TAH (10 implants in the US and 18 outside the US). Twenty-eight devices have been implanted worldwide. Nineteen (68%) patients were female, 4 (14%) were 21 years of age or younger, and 2 (7%) had a diagnosis of congenital heart disease (1 Fontan). The smallest patient, by body surface area, was 1.35 m2. Six patients (21%) have been placed on the Freedom Driver, all of whom have survived. Fourteen patients (50%) have had a positive outcome to date. The development of the 50 cc TAH has expanded the population of patients who may benefit from TAH support and thus may help improve outcomes for patients who have had limited biventricular support options to date.
      To read this article in full you will need to make a payment

      References

        • Copeland J.G.
        • Smith R.G.
        • Arabia F.A.
        • et al.
        Cardiac replacement with a total artificial heart as a bridge to transplantation.
        N Engl J Med. 2004; 351: 859-867
        • Aaronson K.D.
        • Slaughter M.S.
        • Miller L.W.
        • et al.
        Use of an intrapericardial, continuous-flow, centrifugal pump in patients awaiting heart transplantation.
        Circulation. 2012; 125: 3191-3200
        • Slaughter M.S.
        • Rogers J.G.
        • Milano C.A.
        • et al.
        Advanced heart failure treated with continuous-flow left ventricular assist device.
        N Engl J Med. 2009; 361: 2241-2251
        • Moore R.A.
        • Madueme P.C.
        • Lorts A.
        • et al.
        Virtual implantation evaluation of the total artificial heart and compatibility: beyond standard fit criteria.
        J Heart Lung Transplant. 2014; 33: 1180-1183
        • Copeland J.G.
        • Smith R.G.
        • Arabia F.A.
        • et al.
        Total artificial heart bridge to transplantation: a 9-year experience with 62 patients.
        J Heart Lung Transplant. 2004; 23: 823-831
        • Moore R.A.
        • Lorts A.
        • Madueme P.C.
        • et al.
        Virtual implantation of the 50cc SynCardia total artificial heart.
        J Heart Lung Transplant. 2016; 35: 824-827
        • Adachi I.
        • Morales D.S.
        Implantation of total artificial heart in congenital heart disease.
        JoVE. 2014;
        • Kirklin J.K.
        • Naftel D.C.
        • Pagani F.D.
        • et al.
        Seventh INTERMACS annual report: 15,000 patients and counting.
        J Heart Lung Transplant. 2015; 34: 1495-1504
        • Hsich E.M.
        • Naftel D.C.
        • Myers S.L.
        • et al.
        Should women receive left ventricular assist device support?: findings from INTERMACS..
        Circ Heart Fail. 2012; 5: 234-240
        • Blume E.D.
        • Naftel D.C.
        • Bastardi H.J.
        • et al.
        Outcomes of children bridged to heart transplantation with ventricular assist devices: a multi-institutional study.
        Circulation. 2006; 113: 2313-2319
        • Rossano J.W.
        • Lorts A.
        • VanderPluym C.J.
        • et al.
        Outcomes of pediatric patients supported with continuous-flow ventricular assist devices: a report from the Pediatric Interagency Registry for Mechanical Circulatory Support (PediMACS).
        J Heart Lung Transplant. 2016; 35: 585-590
        • Birks E.J.
        • McGee Jr., E.C.
        • Aaronson K.D.
        • et al.
        An examination of survival by sex and race in the HeartWare Ventricular Assist Device for the Treatment of Advanced Heart Failure (ADVANCE) Bridge to Transplant (BTT) and continued access protocol trials.
        J Heart Lung Transplant. 2015; 34: 815-824
        • Cabrera A.G.
        • Sundareswaran K.S.
        • Samayoa A.X.
        • et al.
        Outcomes of pediatric patients supported by the HeartMate II left ventricular assist device in the United States.
        J Heart Lung Transplant. 2013; 32: 1107-1113
        • Schweiger M.
        • Vanderpluym C.
        • Jeewa A.
        • et al.
        Outpatient management of intra-corporeal left ventricular assist device system in children: a multi-center experience.
        Am J Transplant. 2015; 15: 453-460
        • Miera O.
        • Kirk R.
        • Buchholz H.
        • et al.
        A multicenter study of the HeartWare ventricular assist device in small children.
        J Heart Lung Transplant. 2016; 35: 679-681
        • Torregrossa G.
        • Anyanwu A.
        • Zucchetta F.
        • et al.
        SynCardia: the total artificial heart.
        Ann Cardiothorac Surg. 2014; 3: 612-620
        • Rossano J.W.
        • Goldberg D.J.
        • Fuller S.
        • et al.
        Successful use of the total artificial heart in the failing Fontan circulation.
        Ann Thorac Surg. 2014; 97: 1438-1440
        • Marelli A.J.
        • Ionescu-Ittu R.
        • Mackie A.S.
        • et al.
        Lifetime prevalence of congenital heart disease in the general population from 2000 to 2010.
        Circulation. 2014; 130: 749-756
        • Marelli A.J.
        • Mackie A.S.
        • Ionescu-Ittu R.
        • et al.
        Congenital heart disease in the general population: Changing prevalence and age distribution.
        Circulation. 2007; 115: 163-172
        • Diller G.P.
        • Kempny A.
        • Alonso-Gonzalez R.
        • et al.
        Survival prospects and circumstances of death in contemporary adult congenital heart disease patients under follow-up at a large tertiary centre.
        Circulation. 2015; 132: 2118-2125
      1. Arabia F, Gregoric I, Kasirajan V, et al. Total artificial heart (TAH): survival outcomes, risk factors, adverse events in Intermacs. J Heart Lung Transplant 2016;35:S95.

        • Shah K.B.
        • Thanavaro K.L.
        • Tang D.G.
        • et al.
        Impact of INTERMACS profile on clinical outcomes for patients supported with the total artificial heart.
        J Card Fail. 2016; (in press)